Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH), the innate immunity company developing first-in-class therapeutic antibodies for cancer and inflammatory diseases, announces today its tentative financial calendar for 2015, which is set as follows:
February 19, 2015: Publication of 2014 financial statements, with management comments. The 2014 Reference Document and Financial Report (included in the Reference Document) will be released during the second quarter of 2015
April 27, 2015: Annual shareholders meeting in Marseille
May 5, 2015: Publication of revenue for 1Q2015, with management comments
September 17, 2015: Publication of financial statements as of June 30, 2015, with management comments
November 5, 2015: Publication of revenue for 3Q2015, with management comments
In the first quarter of 2015, Innate Pharma management will be present at the following investor conferences:
- Oddo Midcap Forum - Lyon, January 8-9, 2015
- J.P. Morgan 33rd Annual Healthcare Conference - San Francisco, CA, January 12-15, 2015
- Leerink Global Healthcare Conference - New York, NY, February 11-12, 2015
- Credit Suisse Global Healthcare Conference - London, March 3-4, 2015
Innate Pharma is committed to meet on a regular basis with the financial community. All corporate information on the Company, such as its financial statements or its corporate presentations, is available on the Company’s website in the Investors’ section (www.innate-pharma.com/en/financials).
| CP en français | 71.99 KB |
| PR in English | 71.38 KB |